MedTrace Logo

Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects

NCT07301203 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-24

No results posted yet for this study

Summary

This is a Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of CPD704 inhalation suspension in healthy Chinese adult subjects.

Conditions

  • Healthy
  • Healthy Participants

Interventions

DRUG

CPD704 Inhalation Suspension

This trial employs standard jet nebulizers (air-compression nebulizers) for oral inhalation administration。

OTHER

CPD704 placebo

The placebo is administered via standard jet nebulizer (air-compression nebulizer) for oral inhalation

Sponsors & Collaborators

  • Beijing Tide Pharmaceutical Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-21
Primary Completion
2026-06-08
Completion
2026-07-18

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07301203 on ClinicalTrials.gov